The estimated Net Worth of James W Green is at least $12.4 Milione dollars as of 13 June 2024. Mr. Green owns over 10,000 units of Harvard Bioscience stock worth over $8,804,388 and over the last 10 years he sold HBIO stock worth over $1,142,739. In addition, he makes $2,422,600 as Chairman of the Board, President e Chief Executive Officer at Harvard Bioscience.
James has made over 30 trades of the Harvard Bioscience stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of HBIO stock worth $29,100 on 13 June 2024.
The largest trade he's ever made was exercising 54,064 units of Harvard Bioscience stock on 19 May 2021 worth over $142,188. On average, James trades about 7,354 units every 45 days since 2015. As of 13 June 2024 he still owns at least 3,111,091 units of Harvard Bioscience stock.
You can see the complete history of Mr. Green stock trades at the bottom of the page.
James W. Green serves as Chairman of the Board, President, Chief Executive Officer of the Company. Immediately prior to becoming our President and Chief Executive Officer, Mr. Green served as President of Spacelabs Healthcare, a manufacturer of medical equipment, beginning in April 2018. Prior to that position, Mr. Green was General Partner of Grantchester Group, a private equity investment firm with experience in healthcare and technology. Mr. Green also previously served as President, Chief Executive Officer and a Director of Analogic Corporation, a leading publicly held advanced medical and security imaging company from 2007 until October 2016. From 2005 to 2007, Mr. Green worked as Regional Vice President of Unilab Corp., a California division of Quest Diagnostics Corporation. From 1983 to 2005, Mr. Green worked in various other leadership positions at Koninklijke Philips Electronics NV, St. Jude Medical Inc., Beckman Instruments, McDonnell Douglas Corporation and Northrop Advanced Systems. Mr. Green holds a B.S. from the University of Missouri at Columbia, an M.S. from the University of Southern California and is a graduate of the Stanford University Executive Program.
As the Chairman of the Board, President e Chief Executive Officer of Harvard Bioscience, the total compensation of James Green at Harvard Bioscience is $2,422,600. There are no executives at Harvard Bioscience getting paid more.
James Green is 61, he's been the Chairman of the Board, President e Chief Executive Officer of Harvard Bioscience since 2019. There are 3 older and 8 younger executives at Harvard Bioscience. The oldest executive at Harvard Bioscience Inc. is John Kennedy, 71, who is the Independent Director.
James's mailing address filed with the SEC is C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD, HOLLISTON, MA, 01746.
Over the last 21 years, insiders at Harvard Bioscience have traded over $10,145,146 worth of Harvard Bioscience stock and bought 754,658 units worth $2,380,232 . The most active insiders traders include Earl R Lewis, Bertrand Loy e David Green. On average, Harvard Bioscience executives and independent directors trade stock every 43 days with the average trade being worth of $182,054. The most recent stock trade was executed by James W Green on 13 June 2024, trading 10,000 units of HBIO stock currently worth $29,100.
harvard bioscience is a global developer, manufacturer and marketer of a broad range of specialized products, primarily apparatus and scientific instruments used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. we sell our products to thousands of researchers in over 100 countries through our full-line catalog (and various other specialty catalogs), our websites, and through distributors, including ge healthcare, thermo fisher scientific inc., and vwr. we have sales and manufacturing operations in the united states, the united kingdom, germany, and spain and sales facilities in france and canada.
Harvard Bioscience executives and other stock owners filed with the SEC include: